Clinical ink Appoints Andrew Kraus as Chief Technology Officer
Clinical Ink, a global life science technology company, has announced the appointment of Andrew Kraus as chief technology officer. In this role, Kraus will lead the development of the company’s expanding technology portfolio to support clinical trials. Kraus is an accomplished global healthcare executive with a 30-year track record of successful innovation in clinical trials, leveraging his background in technology, strategy, operations, and finance. Prior to Clinical Ink, Kraus served as chief operating officer for World Care Clinical, a contract research organization (CRO) providing centralized imaging...